Login / Signup

Percutaneous tibial neuromodulation initial therapy compliance and subsequent third-line treatment patterns.

Priya PadmanabhanBernadette M M ZwaansCharlotte WuRyan J Boldt
Published in: Neurourology and urodynamics (2024)
Most patients are noncompliant with recommended PTNM treatment regimen. Albeit low, third-line therapy was pursued more frequently by noncompliant patients. Given low compliance, the effectiveness of PTNM may be compromised. Alternative implantable technologies may be needed to assure effectiveness of neuromodulation.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • randomized controlled trial
  • systematic review
  • peritoneal dialysis
  • combination therapy
  • ultrasound guided
  • patient reported
  • cell therapy